A. Alfred Taubman Medical Research Institute - where scientists create cures. University of Michigan Health System
FDA approves Phase II of
ALS stem cell trial
FDA approves next step in Dr. Eva Feldman's clinical
trial of groundbreaking treatment for ALS.
Approval clears way for expanded U-M clinical trial role.
Read the full story >
Dr. Max Wicha: Why cancer stem cells are the new frontier
The Taubman Institute launched a new Health Science Lecture Series with a talk by Taubman Scholar Dr. Max Wicha, director of the U-M Comprehensive Cancer Center and a pioneer in cancer stem cell discovery.
Stem cell surgery targets ALS
Patients glean hope from trial’s progress but wish it were faster
Donors pitch in to keep brilliant science minds at U-M
Emerging Scholars program connects promising M.D.-researchers with philanthropists
Taubman Institute, JDRF announce
Healthy Eyes Scholar
JDRF and Ford Motor Company Fund
enable research on diabetic eye disease
Read the full story >
Dr. Eva Feldman discusses ALS on PBS "Second Opinion" program
Taubman Institute Director Eva Feldman, M.D., Ph.D. was among four panelists invited to discuss amyotrophic lateral sclerosis (ALS)
Taubman Science
ALS patient feels great after stem cell transplant
Took part in Phase I of Dr. Eva Feldman's human clinical trial
Ted Harada tells Crain's Detroit Business that nearly nine months after receiving stem cell injections to his spinal cord, improvement persists.
Click here to read the interview
Clinical Trials
The birth of two human clinical trials
The Taubman Institute’s overriding purpose is to discover potential new treatments that can be tested in clinical trials. Watch as two Taubman Scholars explain how they made it happen.
Taubman Science
Institute training video helps physicians overseas
U-M exam method for diabetic nerve damage translated to Mandarin Chinese. The Taubman institute has produced video of an exam protocol that will help doctors in Asia and elsewhere as they grapple with growing diabetes epidemics and the resulting complications.
news & events
The Latest
Taubman Science
Taubman Scholars direct 31 human clinical trials
Science funded by the Taubman Institute has led to 31 current human clinical trials, studying potential therapies for diseases including breast cancer, muscular dystrophy, diabetes and ALS. See the complete list of trials.
People who care
Generous donors fund institute's summer students
Leadership advisory board members fund Tauber Family Student Internship Program
Three future medical scientists will work with Taubman Institute researchers starting in June.
Accomplishments
State leaders laud Taubman Institute accomplishments
Leaders of state and local government visited the Taubman Institute on March 18 to tour Taubman Scholar labs and discuss the potential medical research offers for both improving the health of residents and establishing new jobs and businesses in Michigan.
Discovery-driven research that matters
Taubman Scholar Dr. Charles Burant tests promising diabetes drugTAK-875, a new treatment for type 2 diabetes, improves blood sugar control and is equally effective as glimepiride, but has a significantly lower risk of creating a dangerous drop in blood sugar, called hypoglycemia, according to a new study. |
Taubman Institute leaders make the case for more doctor-scientist funding
The prestigious "Academic Medicine" journal has just published a new article authored by Taubman Institute senior management and Detroit-area attorney Scott Roberts. The article explores the problematic gap between bench research and clinical application of new treatments or cures. |
Help Us Make A Difference. Make A Gift.
Leaders from the realms of business, academia and the community help to refine the Taubman Institute's vision, to monitor progress and to provide support, advice and counsel.
Meet the Leadership Advisory Board
Meet the Scientific Advisory Board
Links that may be of further interest...
|
Program for Neurology Research & Discovery Consortium for Stem Cell Therapies |
|
About Taubman Institute Video
In this video feature, Taubman Scholars explain why funding for high-risk research is so important to their work and to the discovery of promising cures and treatments.
Stem cell surgery targets ALS Video
Patients glean hope from trial’s progress but wish it were faster
Donors pitch in to keep brilliant science minds at U-M Video
Emerging Scholars program connects promising M.D.-researchers with philanthropists
